• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

The Correction in AstraZeneca Could Be Nearing an End

Aggressive traders might want to look past any near-term price weakness and consider a small long position.
By BRUCE KAMICH
Jan 04, 2021 | 08:21 AM EST
Stocks quotes in this article: AZN

AstraZeneca PLC (AZN) is getting plenty of media attention as Britain began rolling out the coronavirus vaccine developed by AZN and the University of Oxford. The stock has been sliding lower since it made a sharp run up into July. Let's check out the charts and indicators to see if this pullback is in its last stages. 

(For more on AZN, see Jim Cramer: Here's My Plan to Distribute the Vaccine) 

In this daily bar chart of AZN, below, we can see a pattern of lower lows and lower highs - the simple definition of a downtrend. Prices are trading below the bearish 50-day moving average line. It is bearish because its slope is negative.
 
AZN is also trading below the still rising 200-day moving average line. The 50-day line is also slipping below the 200-day line for a bearish dead or death cross. Obviously this signal is late to the game. Trading volume was heavy back in July at the price peak and also in the past month.
 
The On-Balance-Volume (OBV) line turned sharply lower in July as sellers turned very aggressive but the movement in the OBV line in December is perhaps bullish with a number of sharp upswings.
 
The Moving Average Convergence Divergence (MACD) oscillator is ready to cross to the upside from below the zero line. This will be a cover shorts buy signal. 
 
 
In this weekly bar chart of AZN, below, we can see a bearish picture. Prices are trading below the still rising 40-week moving average line. The underside of the 40-week line could become resistance on a bounce.
 
The weekly OBV line shows a peak back in May and is still declining. The MACD oscillator is now crossing the zero line for an outright sell signal.  
 
 
In this daily Point and Figure chart of AZN, below, we can see that the software is projecting a downside price target around $43. The software "sees" the X's and O's since May (look for the "5" on the chart) as distribution or selling. A rally to $55 or $56 is probably needed to turn the chart more positive.  
 
 
 
Bottom line strategy: AZN has been correcting lower for several months and we still have a potential downside price target of $43, but aggressive traders might want to look past any near-term price weakness and consider a small long position risking to $47.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Drug Approvals | Investing | Markets | Stocks | Technical Analysis | Trading | Healthcare | Pharmaceuticals | Coronavirus

More from Investing

When it Comes Time to Sell, Will You Act or Will You Freeze?

James "Rev Shark" DePorre
Jan 16, 2021 10:00 AM EST

Why don't more people embrace the ease and power of selling stocks? Why do they freeze and do nothing as losses build?

Cybersecurity Stocks that Lagged in 2020 Could Get Boost from SolarWinds Hack

Eric Jhonsa
Jan 16, 2021 8:00 AM EST

The hack stands to drive an uptick in corporate and government spending to protect both on-premise and cloud assets.

Hungry Traders and Stock Opportunities Aren't Likely to Go Away Soon

James "Rev Shark" DePorre
Jan 15, 2021 4:40 PM EST

It doesn't take much time for stocks with strong momentum to reset and continue on their way.

At What Price Is Ballard Power Systems a Buy?

Bruce Kamich
Jan 15, 2021 3:09 PM EST

Let's check out the latest charts of BLDP.

United Parcel Service Is Testing Key Support

Bruce Kamich
Jan 15, 2021 2:30 PM EST

A look at the charts of UPS.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    When it's time to sell, will you act or freeze?
  • 08:35 AM EST GARY BERMAN

    Wednesday Morning Fibocall for 1/13/2021

    Lower highs... SPX (Long-Term View) The 1/8/2...
  • 08:07 AM EST GARY BERMAN

    Tuesday Morning Fibocall for 1/12/2021

    Watch if the recent trend of lower highs continues...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login